PGII Rapid Quantitative Test

Human Pepsinogens are aspartic proteases produced in the gastric mucosa and secreted into the gastric lumen that play a major role in the digestion of proteins after activation of acidic pH. It is synthesized as isoymogens and is classified into two groups (Pepsinogen I and Pepsinogen II).

PGI Rapid Quantitative Test

PGI/PGII Rapid Quantitative Test

Human pepsinogens I (PGI) and II (PGII) are proenzymes of pepsin—an endoproteinase of gastric juice. PGI is secreted mainly by chief cells in the fundic mucosa, whereas PGII is also secreted by the pyloric glands and the proximal duodenal mucosa. Serum PGI and PGII concentrations and the ratio between PGI and PGII may be related to the histologic and functional status of the gastric mucosa.

SARS-CoV-2 Antigen Rapid Qualitative Test Type A

PCT Rapid Quantitative Test (Chemiluminescence Immunoassay)

PCT Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Procalcitonin concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of inflammation diseases.

S100-β Rapid Quantitative Test (Fluorescence Immunoassay)

The Biotime S100-β Rapid Quantitative Test is intended to quantify the concentration of S100-β in human serum, plasma, and whole blood on the Biotime FIA Analyzer by fluorescent immunoassay. The test is used as an aid in the detection of neurological injury.

SARS-CoV-2 IgG/IgM Rapid Qualitative Test

The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.

TESTO Rapid Quantitative Test (Chemiluminescence Immunoassay)

TESTO Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the Testosterone (TESTO) concentration in human serum and plasma that contains heparin /EDTA and other anticoagulants samples, mainly used for auxiliary diagnosis of reproductive hormones diseases.

h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay)

h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the heart-type fatty acid binding protein (h-FABP) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

Specimen Types	Serum
Specimen Capacity	10μL
Reaction Time	15 min
Sample Capacity	80μL
PGII Detection Range	0.5-200.0ng/mL

Fluorescence Immunoassay

Gastrointestinal Marker

PGII Rapid Quantitative Test